Table 2.
Preferred term | AMG 181 n = 50 n (%) | Placebo n = 18 n (%) |
---|---|---|
Any adverse event | 30 (60) | 9 (50) |
Upper respiratory tract infection | 15 (30) | 1 (6) |
Headache | 8 (16) | 1 (6) |
Oropharyngeal pain | 3 (6) | 1 (6) |
Diarrhoea | 1 (2) | 2 (11) |
Nausea | 2 (4) | 1 (6) |
Dizziness | 2 (4) | 0 (0) |
Abdominal pain | 0 (0) | 2 (11) |
Fatigue | 1 (2) | 1 (6) |
Syncope | 1 (2) | 1 (6) |
Viral infection | 1 (2) | 1 (6) |